Pia Glas-Greenwalt

1.2k total citations
29 papers, 933 citations indexed

About

Pia Glas-Greenwalt is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Cancer Research. According to data from OpenAlex, Pia Glas-Greenwalt has authored 29 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Hematology and 6 papers in Cancer Research. Recurrent topics in Pia Glas-Greenwalt's work include Blood properties and coagulation (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Protease and Inhibitor Mechanisms (6 papers). Pia Glas-Greenwalt is often cited by papers focused on Blood properties and coagulation (9 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers) and Protease and Inhibitor Mechanisms (6 papers). Pia Glas-Greenwalt collaborates with scholars based in United States. Pia Glas-Greenwalt's co-authors include Victor E. Pollak, Tage Astrup, Sixtus Thorsen, Uno Barcelli, L. Maximilian Buja, J McNatt, Paolo Golino, J H Ashton, J. T. Willerson and Pollak Ve and has published in prestigious journals such as Circulation, Blood and CHEST Journal.

In The Last Decade

Pia Glas-Greenwalt

28 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pia Glas-Greenwalt United States 17 273 225 210 209 160 29 933
A Blann United Kingdom 15 189 0.7× 246 1.1× 141 0.7× 200 1.0× 65 0.4× 17 1.2k
B. Bottasso Italy 21 677 2.5× 283 1.3× 175 0.8× 216 1.0× 43 0.3× 38 1.5k
Karen L. Kaplan United States 20 421 1.5× 313 1.4× 259 1.2× 198 0.9× 62 0.4× 46 1.3k
Carla Boschetti Italy 18 340 1.2× 209 0.9× 276 1.3× 211 1.0× 91 0.6× 48 1.1k
Hajime Tsuji Japan 18 399 1.5× 334 1.5× 88 0.4× 115 0.6× 79 0.5× 70 992
Helen Ireland United Kingdom 20 500 1.8× 260 1.2× 77 0.4× 185 0.9× 55 0.3× 30 1.1k
Jim Thom Australia 17 473 1.7× 401 1.8× 111 0.5× 211 1.0× 53 0.3× 29 1.0k
Akira Shouzu Japan 21 170 0.6× 423 1.9× 95 0.5× 217 1.0× 178 1.1× 34 1.3k
Thomas K. Nordt Germany 19 356 1.3× 560 2.5× 318 1.5× 450 2.2× 312 1.9× 33 1.7k
Maurice Redondo Switzerland 8 438 1.6× 275 1.2× 83 0.4× 140 0.7× 39 0.2× 10 896

Countries citing papers authored by Pia Glas-Greenwalt

Since Specialization
Citations

This map shows the geographic impact of Pia Glas-Greenwalt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pia Glas-Greenwalt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pia Glas-Greenwalt more than expected).

Fields of papers citing papers by Pia Glas-Greenwalt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pia Glas-Greenwalt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pia Glas-Greenwalt. The network helps show where Pia Glas-Greenwalt may publish in the future.

Co-authorship network of co-authors of Pia Glas-Greenwalt

This figure shows the co-authorship network connecting the top 25 collaborators of Pia Glas-Greenwalt. A scholar is included among the top collaborators of Pia Glas-Greenwalt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pia Glas-Greenwalt. Pia Glas-Greenwalt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glas-Greenwalt, Pia. (1995). Fibrinolysis in Disease: The Malignant Process, Interventions in Thrombogenic Mechanisms, and Novel Treatment Modalities. Medical Entomology and Zoology. 3 indexed citations
2.
Yao, Sheng, J McNatt, H. Vernon Anderson, et al.. (1992). Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion. American Journal of Physiology-Heart and Circulatory Physiology. 262(2). H374–H379. 21 indexed citations
3.
Sawaya, Raymond & Pia Glas-Greenwalt. (1992). Postoperative venous thromboembolism and brain tumors: part II. Hemostatic profile. Journal of Neuro-Oncology. 14(2). 127–34. 36 indexed citations
4.
Glas-Greenwalt, Pia. (1992). Safe and successful clinical use of the defibrinogenating agent ancrod.. Blood. 80(6). 1626–8. 2 indexed citations
5.
Sawaya, Raymond, et al.. (1991). Plasma Fibrinolytic Profile in Patients with Brain Tumors. Thrombosis and Haemostasis. 65(1). 15–19. 27 indexed citations
6.
Pollak, Victor E., Pia Glas-Greenwalt, Charles P. Olinger, Nand K. Wadhwa, & Steven A. Myre. (1990). Ancrod Causes Rapid Thrombolysis in Patients with Acute Stroke. The American Journal of the Medical Sciences. 299(5). 319–325. 41 indexed citations
7.
Ito, Yasushi, et al.. (1988). Fish oil has beneficial effects on lipids and renal disease of nephrotic rats. Metabolism. 37(4). 352–357. 23 indexed citations
8.
Olinger, Charles P., Thomas G. Brott, William G. Barsan, et al.. (1988). Use of ancrod in acute or progressing ischemic cerebral infarction. Annals of Emergency Medicine. 17(11). 1208–1209. 43 indexed citations
9.
Golino, Paolo, J H Ashton, Pia Glas-Greenwalt, et al.. (1988). Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis.. Circulation. 77(3). 678–684. 119 indexed citations
10.
Wadhwa, Nand K., K. Shashi Kant, Victor E. Pollak, et al.. (1988). Fibrinolysis in Glomerulonephritis Treated With Ancrod: Renal Functional, Immunologic and Histopathologic Effects. QJM. 69(259). 879–905. 17 indexed citations
11.
Apprill, Phillip, J H Ashton, J. Luis Guerrero, et al.. (1987). Ancrod decreases the frequency of cyclic flow variations and causes thrombolysis following acute coronary thrombosis. American Heart Journal. 113(4). 898–906. 5 indexed citations
12.
Ve, Pollak, et al.. (1985). Lupus nephritis with thrombosis and abnormal fibrinolysis: effect of ancrod.. PubMed. 105(1). 77–88. 31 indexed citations
13.
Glas-Greenwalt, Pia, et al.. (1985). Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).. PubMed. 24(4). 186–91. 13 indexed citations
14.
Glas-Greenwalt, Pia, et al.. (1984). Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.. PubMed. 104(6). 962–76. 50 indexed citations
15.
Glas-Greenwalt, Pia, et al.. (1984). Abnormalities of fibrinolysis in essential hypertension.. PubMed. 2(3). S175–8. 2 indexed citations
16.
Munda, R, et al.. (1983). Prolongation of survival of a heart xenograft by defibrination with ancrod.. PubMed. 35(6). 620–2. 8 indexed citations
18.
Glas-Greenwalt, Pia, et al.. (1972). Primary Pulmonary Aspergillosis with High Fibrinolytic Activity in the Aortic Intima. CHEST Journal. 61(4). 394–396. 4 indexed citations
19.
Glas-Greenwalt, Pia, et al.. (1972). Fibrinolytic activity in the closed ductus arteriosus. Cellular and Molecular Life Sciences. 28(4). 448–449. 1 indexed citations
20.
Glas-Greenwalt, Pia, Fritz Karl Beller, & Tage Astrup. (1971). Comparative assays of tissue plasminogen activator in myometrium, cervix, and fibromyomas of the human uterus. American Journal of Obstetrics and Gynecology. 110(5). 721–725. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026